{"nct_id":"NCT02031276","title":"Efficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease.","status":"COMPLETED","status_verified_date":"2018-10","start_date":"2014-02","start_date_type":"ACTUAL","primary_completion_date":"2015-12","primary_completion_date_type":"ACTUAL","completion_date":"2016-11","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}